Century Therapeutics (IPSC) Registration Filing summary

Management team and governance

• President and CEO is Brent Pfeiffenberger, PharmD, MBA, who also serves as Chairman of the Board of Directors.

• Senior Vice President, Finance (Principal Financial Officer and Principal Accounting Officer) is Douglas Carr, CPA.

• Board includes directors with advanced degrees in medicine, science, and business.

Offering details and pricing

• Registration statement filed on Form S-3 for a shelf offering, allowing securities to be sold from time to time after effectiveness.

• Securities registered include common stock, preferred stock, debt securities, warrants, units, and subscription rights.

• No new SEC registration fee required; fee carried forward from prior registration statement.

Use of proceeds and capital allocation

• Expenses related to issuance and distribution include legal, accounting, trustee, transfer agent, and listing fees, with amounts dependent on future offerings.